CLINICAL_TRIALS
research
· 2013-03-14
Clinical Trial Update: START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism [NA]
Summary
This document provides an update on the START trial evaluating early thrombocyte (platelet) administration in patients with ruptured abdominal aortic aneurysm. …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rigshospitalet, Denmark | Conditions: Ruptured Abdominal Aortic Aneurism | NA | Status: UNKNOWN